📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation. (2013)

First Author: Stasiuk GJ

Attributed to: Confidence in Concept 2012 - Imperial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c2cc37460a

PubMed Identifier: 23208551

Publication URI: http://europepmc.org/abstract/MED/23208551

Type: Journal Article/Review

Volume: 49

Parent Publication: Chemical communications (Cambridge, England)

Issue: 6

ISSN: 1359-7345